Edward Chong

A Randomized Clinical Trial of Anti–IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection

Konstantin Doberer, Michael Duerr, Philip F. Halloran et al. · Journal of the American Society of Nephrology · 2020 · 175 citations · Full text

Life Sciences, Immunology, Nephrology +16

Frailty and Risk of Adverse Outcomes in Hospitalized Older Adults: A Comparison of Different Frailty Measures

Edward Chong, Esther Ho, Jewel Baldevarona-Llego et al. · Journal of the American Medical Directors Association · 2017 · 144 citations

Medicine, Geriatric Medicine, Frailty +15

Frailty in Hospitalized Older Adults: Comparing Different Frailty Measures in Predicting Short- and Long-term Patient Outcomes

Edward Chong, Esther Ho, Jewel Baldevarona-Llego et al. · Journal of the American Medical Directors Association · 2017 · 122 citations

Medicine, Geriatric Medicine, Frailty +15

Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial

Farsad Eskandary, Michael Dürr, Klemens Budde et al. · Trials · 2019 · 64 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Change in Estimated GFR and Risk of Allograft Failure in Patients Diagnosed With Late Active Antibody-mediated Rejection Following Kidney Transplantation

William Irish, Peter Nickerson, Brad C. Astor et al. · Transplantation · 2020 · 47 citations · Full text

Medicine, Nephrology, Surgery +17